Cytosolic DNA-sensing pathways in BRCA1-deficient breast cancer development
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210493
- Recipient
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1 Part of Partners Healthcare System Incorporated
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,523,784
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Funding
-
- $761,892.00 Federal
- $761,892.00 Non-federal
- Place of performance
- Boston, MA 02115, USA
Award details come from USAspending.gov.
About this award
Brigham & Women's Hospital Inc. was awarded a $1,523,784 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program to investigate cytoplasmic DNA-sensing pathways in BRCA1-deficient breast cancer development. The three-year award beginning July 1, 2022 will support research into medical solutions for breast cancer at the cellular level through studying the role of cytoplasmic DNA sensors in breast cancer tumor growth associated with BRCA1 gene mutations. As the prime awardee, Brigham & Women's Hospital will lead this research effort to transform healthcare and investigate medical battlefield solutions as called for under the Military Medical Research and Development program's mission to support innovative biomedical research.
Quick answers
Who received award W81XWH2210493?
W81XWH2210493 was awarded to Brigham & Womens Hospital Inc. by Medical Command (Department of the Army) on July 1, 2022.
How much is award W81XWH2210493 worth?
$1,523,784 has been obligated on W81XWH2210493: $761,892 in federal funding and $761,892 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award